BioCentury
ARTICLE | Company News

Houghten other research news

September 19, 1994 7:00 AM UTC

The San Diego company was awarded two Phase I SBIR grants totaling $135,000. A grant from the National Institute of Drug Abuse will fund in vivo testing of specific antagonists of opioid action on the...